Jul 27, 2026 08:30AM

Jul 27, 2026 08:30AM

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM

Jun 30, 2026 08:30AM

Jun 30, 2026 08:30AM

Jun 3, 2026 08:30AM Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

May 6, 2026 04:05PM

Mar 25, 2026 08:05AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 19, 2026 08:30AM Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®

Mar 16, 2026 08:34AM

Mar 16, 2026 08:33AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 12:00PM

Feb 25, 2026 04:05PM

Feb 24, 2026 09:08AM Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan

Feb 24, 2026 09:07AM

Jan 26, 2026 08:01AM

Jan 26, 2026 08:00AM

Jan 12, 2026 11:59AM

Jan 12, 2026 11:58AM

Jan 12, 2026 09:30AM

Dec 9, 2025 06:50AM Wedbush Starts Sarepta Therapeutics (SRPT) at Outperform

Nov 25, 2025 08:58AM

Nov 25, 2025 08:57AM

Nov 24, 2025 07:31AM

Nov 24, 2025 07:30AM

Nov 20, 2025 03:59AM

Nov 14, 2025 02:59PM

Nov 14, 2025 02:54PM Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information

Nov 14, 2025 02:02PM

Nov 3, 2025 04:13PM

Nov 3, 2025 04:05PM

Oct 3, 2025 08:30AM

Aug 13, 2025 04:13PM

Aug 13, 2025 04:12PM

Aug 12, 2025 01:25PM Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending - Hagens Berman

Aug 11, 2025 01:59PM

Aug 6, 2025 04:05PM

Aug 5, 2025 06:28PM

Jul 30, 2025 08:07AM

Jul 30, 2025 06:40AM

Jul 29, 2025 10:27AM

Jul 29, 2025 10:05AM Barclays Upgrades Sarepta Therapeutics (SRPT) to Equalweight

Jul 29, 2025 09:37AM

326,536 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All